lobbying_activities: 1153336

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1153336	925f7618-5274-4581-ba80-eb6536eb0c3e	Q3	EISAI INC.	400321512	EISAI INC.	2011	third_quarter	PHA	Prescription Drug User Fee Act reauthorization. FDA-DEA issues Maintain current 340B program Maintain current exclusivity period for innovator biologics	Education, Dept of,HOUSE OF REPRESENTATIVES,SENATE		785000	0	0	2011-10-18T11:02:46.637000-04:00